Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Cyclooxygenase-inhibitory indoles under study at Pfizer

March 8, 1999

Cytokine production inhibitors prepared and tested at Ortho-McNeil

March 4, 1999

Medarex joins forces with Danish investors to develop human antibody therapeutics

March 4, 1999

Cysteine protease-inhibitory peptides disclosed by Takeda

March 2, 1999

New MMP and/or TNF production inhibitors developed by Pfizer research group

March 2, 1999

Clinical study of La Jolla's lupus drug expanded to Europe and Canada

March 2, 1999

Zimmer launches Orthovisc in Europe; prepares to begin North American trials

Feb. 26, 1999

Rofecoxib up for advisory committee review this spring

Feb. 26, 1999

Clinically effective antiarthritic drug offered for licensing by KS Biomedix

Feb. 26, 1999

Preclinical study confirms antiinflammatory activity of raxofelast

Feb. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...